Enzymatic reduction of arsenic compounds in mammalian systems: Reduction of arsenate to arsenite by human liver arsenate reductase

Citation
Tr. Radabaugh et Hv. Aposhian, Enzymatic reduction of arsenic compounds in mammalian systems: Reduction of arsenate to arsenite by human liver arsenate reductase, CHEM RES T, 13(1), 2000, pp. 26-30
Citations number
26
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CHEMICAL RESEARCH IN TOXICOLOGY
ISSN journal
0893228X → ACNP
Volume
13
Issue
1
Year of publication
2000
Pages
26 - 30
Database
ISI
SICI code
0893-228X(200001)13:1<26:EROACI>2.0.ZU;2-X
Abstract
An arsenate (As-v) reductase has been partially purified from human liver. Its apparent molecular mass is approximately 72 kDa.The enzyme required a t hiol and a heat stable cofactor for activity. The cofactor is less than 3 k Da in size. The thiol requirement can be satisfied by dithiothreitol (DTT). However, the extent of stimulation of reductase activity by glutathione, t hioredoxin, or reduced lipoic acid was negligible compared to that of DTT. The heat stable cofactor does not appear to be Cu2+, Mn2+ Zn2+, Mg2+, or Ca 2+. The enzyme does not reduce monomethylarsonic acid (MMA(v)). The isolati on and characterization of this enzyme demonstrates that in humans, the red uction of arsenate to arsenite is enzymatically catalyzed and is not solely the result of chemical reduction by glutathione as has been proposed in th e past.